(Q54717063)

3 June 2018

title

TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients. (English)

1 reference

3 June 2018

main subject

biomarker

0 references

toll-like receptor

0 references

coronary artery disease

1 reference

Liang Shao

1

1 reference

3 June 2018

Ping Zhang

2

1 reference

3 June 2018

Yong Zhang

3

1 reference

3 June 2018

Qun Lu

4

1 reference

3 June 2018

Aiqun Ma

5

1 reference

3 June 2018

publication date

22 October 2013

1 reference

3 June 2018

published in

Heart and Vessels

1 reference

3 June 2018

volume

29

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

690-698

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1007/s00380-013-0421-3

exact match

0 references

cites work

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Left circumflex coronary artery is protected against no-reflow phenomenon following percutaneous coronary intervention for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Relation of plaque lipid composition and morphology to the stability of human aortic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Toll-like receptors and their function in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

The expression and functions of toll-like receptors in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Toll-like receptors induce a phagocytic gene program through p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Alternative activation of macrophages: mechanism and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Unexpected protective role for Toll-like receptor 3 in the arterial wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0421-3

Inflammation and atherosclerosis

21 January 2018

1 reference

12 December 2020

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Atrial endothelial impairment through Toll-like receptor 4 signaling causes atrial thrombogenesis

1 reference

12 December 2020

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

12 December 2020

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

1 reference

12 December 2020

The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications

1 reference

12 December 2020

10.1007/S00380-013-0421-3

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018